You are here: Industry Insights > Generic Drugs

News List

Western Medicine Preparation Exportation of Chinese Pharmaceutical Enterprises to the U.S.(1) Xiaoyaowan
September 19, 2018
278 ANDA Approvals! A Quick Look at the Western Medicine Preparation Exportation of Chinese Pharmaceutical Enterprises to the U.S.
Motivating Generic Drugs from Multiple Points, China is still a Big Generic Drug Country Muzi
July 10, 2018
China has achieved breakthrough progress in terms of the new drug development speed in recent years, however, China started later than the developed countries in Europe and America in drug development...
Which of the Blockbuster Drugs on the Autoimmune Drug Market Will Show the Glory that Humira Had?(2) Siyi
June 06, 2018
Enbrel and Remicade have begun to suffer impacts of generic drugs, with market shares largely reducing.
Generic antiplatelet drugs are as effective as brand name counterpart europeanpharmaceuticalreview
March 15, 2018
A study in Canada has demonstrated that generic antiplatelet drugs appear to be as equally effective as a brand name drug for heart patients.
Update on Priority Review by CDE: Biggest Bright Spot Being the Inclusion of Novartis’ LCZ696 cccmhpie
January 31, 2018
CDE publicized on December 2 the twelfth batch of registration applications of pharmaceutical products to be included in the priority review procedure, with 32 acceptance numbers in total included in the list.
Which will be the Final Winner on the Market: Original Drugs or Generic Drugs? (2) Y-lp.com
January 26, 2018
The blood lipid regulating drugs are second only to the antineoplastic chemical drugs both on the Chinese and global markets. Statins account for about 90% share on the blood lipid regulating prescription drug market in China.
Which will be the Final Winner on the Market: Original Drugs or Generic Drugs? Y-lp.com
January 25, 2018
The imatinib mesylate is originally developed by Novartis, and indicated for chronic myelogenous leukemia and malignant gastrointestinal stromal tumors.
2016: A Record-setting Year for Generic Drugs FDA
March 01, 2017
Over the last 10 years, generic drugs have saved the U.S. healthcare system about $1.68 trillion. 2016 was a record-setting year for FDA’s generic drug program.

Previous page 1 2 Next page